Oslo, 11 February 2025 - Observe Medical ASA (the "Company" or "Observe
Medical") announces entry into the Indian market with LOI signed with strong
local partner and first order received.
India represents one of the largest and fastest-growing healthcare markets
worldwide and is projected to grow at a compound annual growth rate (CAGR) of
15-18%, with forecasts estimating the countrys healthcare market could reach USD
50 billion by 2030.
Jørgen Mann, CEO of Observe Medical, commented: "We have a established a
partnership with a strong local partner and taken the first order which has been
one of our strategic ambitions due to the size of the market but even more the
Rising Healthcare Expenditure, where Healthcare spending is growing steadily,
supported by both private investment and public sector initiatives, making India
one of the most interesting markets globally."
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available atwww.observemedical.com.